Orgenesis Inc.

ORGSDelisted May 8, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001460602

SEC filings (opens in a new tab)

Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Orgenesis Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of ORGS: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	27	23	−4
Shares	3.05M	2.95M	−100.1K (−3.3%)
Value	$8.78M	$10.2M	+$1.45M (+16.5%)

New holders (1)

Institutions that held Orgenesis Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to ORGS in Q1 2022
Institution	Shares	Value	% of portfolio
Kennedy Capital Management, Inc.	19,514	$68.0K	0.00%

Sold out (5)

Institutions that held Orgenesis Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of ORGS in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Acadian Asset Management LLC	21,762	$62.0K
Citadel Advisors LLC	18,270	$53.0K
Two Sigma Securities, LLC	14,692	$42.0K
Susquehanna International Group, LLP	12,400	$36.0K
UBS Group AG	9,210	$27.0K